Bonesupport Holding AB (publ) (BOEUF)
USD 32.55
(-2.11%)
USD 32.55
(-2.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 13.93 Million SEK | 134.39% |
| 2022 | -64.53 Million SEK | 20.0% |
| 2021 | -80.66 Million SEK | 18.15% |
| 2020 | -98.56 Million SEK | 37.66% |
| 2019 | -158.1 Million SEK | 9.35% |
| 2018 | -174.4 Million SEK | -75.66% |
| 2017 | -99.28 Million SEK | -11.88% |
| 2016 | -88.74 Million SEK | -64.63% |
| 2015 | -53.9 Million SEK | -37.15% |
| 2014 | -39.3 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 25.53 Million SEK | 587.16% |
| 2024 Q3 | 40.96 Million SEK | 37.85% |
| 2024 Q2 | 29.71 Million SEK | 16.37% |
| 2023 Q4 | 3.71 Million SEK | -75.01% |
| 2023 Q2 | 5.95 Million SEK | 675.0% |
| 2023 Q1 | 768 Thousand SEK | 103.98% |
| 2023 Q3 | 14.86 Million SEK | 149.8% |
| 2023 FY | 22.19 Million SEK | 134.39% |
| 2022 FY | -64.53 Million SEK | 20.0% |
| 2022 Q1 | -16.45 Million SEK | 24.42% |
| 2022 Q2 | -14.85 Million SEK | 9.73% |
| 2022 Q4 | -19.28 Million SEK | -38.32% |
| 2022 Q3 | -13.94 Million SEK | 6.15% |
| 2021 Q1 | -19.67 Million SEK | 26.19% |
| 2021 Q4 | -21.77 Million SEK | -63.95% |
| 2021 Q3 | -13.28 Million SEK | 48.8% |
| 2021 Q2 | -25.94 Million SEK | -31.84% |
| 2021 FY | -80.66 Million SEK | 18.15% |
| 2020 Q3 | -19.22 Million SEK | 18.09% |
| 2020 Q4 | -26.65 Million SEK | -38.65% |
| 2020 Q1 | -29.2 Million SEK | 24.33% |
| 2020 Q2 | -23.47 Million SEK | 19.63% |
| 2020 FY | -98.56 Million SEK | 37.66% |
| 2019 Q2 | -47.82 Million SEK | -22.63% |
| 2019 Q4 | -38.59 Million SEK | -18.08% |
| 2019 Q1 | -38.99 Million SEK | 15.84% |
| 2019 FY | -158.1 Million SEK | 9.35% |
| 2019 Q3 | -32.68 Million SEK | 31.64% |
| 2018 Q3 | -57.11 Million SEK | -51.02% |
| 2018 Q1 | -33.13 Million SEK | 0.75% |
| 2018 FY | -174.4 Million SEK | -75.66% |
| 2018 Q4 | -46.33 Million SEK | 18.87% |
| 2018 Q2 | -37.82 Million SEK | -14.16% |
| 2017 Q1 | -27.43 Million SEK | 3.4% |
| 2017 FY | -99.28 Million SEK | -11.88% |
| 2017 Q4 | -33.38 Million SEK | -65.96% |
| 2017 Q3 | -20.11 Million SEK | -9.55% |
| 2017 Q2 | -18.36 Million SEK | 33.07% |
| 2016 Q4 | -28.39 Million SEK | -9.81% |
| 2016 Q2 | -20.82 Million SEK | -52.46% |
| 2016 Q1 | -13.66 Million SEK | 0.0% |
| 2016 FY | -88.74 Million SEK | -64.63% |
| 2016 Q3 | -25.86 Million SEK | -24.18% |
| 2015 FY | -53.9 Million SEK | -37.15% |
| 2014 FY | -39.3 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -1096.509% |
| Ansell Limited | 129.3 Million USD | 89.227% |
| Ansell Limited | 129.3 Million USD | 89.227% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 55.264% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 972.971% |
| Psykey, Inc. | -797.5 Thousand USD | 1846.7% |
| ConvaTec Group Plc | 262.7 Million USD | 94.697% |
| ConvaTec Group Plc | 262.7 Million USD | 94.697% |
| Encision Inc. | -640.78 Thousand USD | 2273.903% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 9923.003% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 12771.7% |
| Innovative MedTech Inc. | -4.27 Million USD | 425.918% |
| LifePoint, Inc. | -7.49 Million USD | 285.852% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 314.969% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -4121.212% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 11435.341% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 3081.095% |
| SmileDirectClub, Inc. | -241.15 Million USD | 105.776% |
| Sector 10, Inc. | -39.84 Thousand USD | 35061.349% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 95.642% |
| SheerVision, Inc. | 155.72 Thousand USD | -8845.199% |
| United Health Products, Inc. | -2.42 Million USD | 674.069% |
| Vasamed, Inc. | 4.74 Million USD | -193.739% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 707.199% |
| Yubo International Biotech Limited | -1.2 Million USD | 1255.803% |